Wednesday, September 19, 2018

It Certainly Won't Move The Needle, But Amazon Web Services Is Now Working With Kenilworth...


Forgive me if I read this as just one subtle but multi-paragraph commercial for the ever-pitching med biz consulting folk at old Accenture.

Becker's Hospital Review has a nice story here -- but it is built upon what is the usual breathless boosterism, out of 161 North Clark in Chicago (Accenture's main digs). I doubt it will lead to any revolutionary, or even evolutionary, drug candidates -- for Merck -- but we shall see. Here's a bit, this morning:

. . . .Merck [and Amazon Web Services] are building an informatics research platform on Amazon's cloud computing service Amazon Web Services to support data-driven drug development.

The cloud-based platform will provide pharmaceutical, biotechnology and scientific institutions with access to research data from various applications, available through a single set of interfaces with integrated workflow and reporting capabilities. Through the platform, these organizations will be able to aggregate and analyze this data to support the early stages of drug development.

Merck, as one of the early collaborators, will be the first pharmaceutical company to use the platform.

The informatics research platform is part of an ongoing collaboration between management consulting and professional services firm Accenture and AWS through the Accenture AWS Business Group. . . .


Now you know. It is a morning literally awash in memories for me. Where is that [pocket sized, purple silken] fall-back disk? Smile. . . . onward.

नमस्ते

No comments: